Alterola Biotech, Inc. ABTI OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • GB • USD

SharesGrow Score

23/100

0/4 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Alterola Biotech, Inc. (ABTI) .

Criteria proven by this page:

VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 21/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score

23/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

HEALTH

50/100

Debt-to-Equity & liquidity

→ Health

✗

MOAT

28/100

→ Income

✗

GROWTH

15/100

→ Income

—

INCOME

N/A

No coverage

Valuation Snapshot — ABTI

Valuation Multiples

P/E (TTM)0.0

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio0.00

P/S Ratio0.00

EV/EBITDA0.0

Per Share Data

EPS (TTM)$0.00

Book Value / Share$0.00

Revenue / Share$0.00

FCF / Share$0.00

Yields & Fair Value

Earnings YieldN/A

Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2014	$0.00	$0.00	$-72.5K	-
2015	$0.00	$0.00	$-54.92K	-
2016	$0.00	$0.00	$-36.13K	-
2017	$0.00	$0.00	$-22.58K	-
2018	$0.00	$0.00	$-86.13K	-
2019	$0.00	$0.00	$-133.07K	-
2020	$0.00	$0.00	$-258.7K	-
2021	$0.00	$0.00	$-171.51K	-
2022	$-0.01	$0.00	$-6.47M	-
2023	$0.00	$0.00	$-1.54M	-